Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine + Rituximab in Elderly CLL
NCT00758693Phase 2Withdrawn
- Sponsor
- University of Kentucky
- Start
- Oct 2008
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in chronic lymphocytic leukemia (CLL), sponsored by University of Kentucky. Planned start Oct 2008; status: withdrawn.
02
Drugs
bendamustine
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00758693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00758693.